CZMWF OTC
Carl Zeiss Meditec AG
1W: +2.1%
1M: +4.5%
3M: +27.4%
YTD: -21.2%
1Y: -23.0%
3Y: -54.2%
5Y: -82.1%
$38.21
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$2.2B
+7.8% ▲
5Y CAGR: +10.8%
Gross Profit
$1.2B
+8.0% ▲
5Y CAGR: +9.5%
Operating Income
$223M
+84.0% ▲
5Y CAGR: +7.0%
Net Income
$141M
-21.0% ▼
5Y CAGR: +2.9%
EPS (Diluted)
$1.61
-19.9% ▼
5Y CAGR: +3.3%
EBITDA
$407M
+80.8% ▲
5Y CAGR: +8.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.9B | $2.1B | $2.1B | $2.2B |
| YoY Growth | +23.3% | +15.5% | +9.8% | -1.1% | +7.8% |
| Cost of Revenue | $680M | $775M | $884M | $977M | $1.1B |
| Gross Profit | $967M | $1.1B | $1.2B | $1.1B | $1.2B |
| Gross Margin | 58.7% | 59.3% | 57.7% | 52.7% | 52.8% |
| R&D Expenses | $232M | $291M | $349M | $343M | $326M |
| SG&A Expenses | $364M | $438M | $504M | $569M | $627M |
| Operating Expenses | $616M | $731M | $879M | $967M | $952M |
| Operating Income | $351M | $397M | $327M | $121M | $223M |
| Operating Margin | 21.3% | 20.9% | 15.7% | 5.9% | 10.0% |
| Interest Expense | $9M | $9M | $2M | $29M | $27M |
| Income Before Tax | $339M | $403M | $413M | $241M | $194M |
| Tax Expense | $102M | $108M | $121M | $61M | $52M |
| Net Income | $236M | $294M | $290M | $179M | $141M |
| Net Margin | 14.3% | 15.4% | 13.9% | 8.7% | 6.3% |
| EPS (Diluted) | $2.64 | $3.29 | $3.25 | $2.01 | $1.61 |
| EBITDA | $410M | $483M | $502M | $225M | $407M |
| Shares Outstanding | 89M | 89M | 89M | 89M | 88M |